A Message from the Editor-in-Chief of Hematology Reports | Updated Impact Factor of 1.1

I am very glad to inform you that Hematology Reports (ISSN: 2038-8330) was awarded an increased Impact Factor of 1.1 in the 2023 Journal Citation Reports™ released by Clarivate. The new IF represents a 22.22% increase compared to our 2022 record of 0.9.

This remarkable increase in impact factor for Hematology Reports underscores the rigorous peer-review process and the high quality of scientific papers that have been published. It clearly demonstrates the important role that this journal has played and will continue to play in advancing scientific knowledge and providing a decision-support tool for the management of hematological malignancies.

I would like to commend our entire Editorial Board, including the Section Editors-in-Chief, the editors of Special Issues and Topical Collections, the Managing Editors, and Assistant Editors, as well as the external referees, and all the members of the Society of Hematologic Oncology Italy—SOHO Italy, for working tirelessly to attract, review, and publish the best scientific discoveries in Hematology Reports. I am grateful for their outstanding contributions to our journal.

My special thanks are also extended to the MPDI leadership for their excellent vision in guiding the robust development of our journal.

Dr. Claudio Cerchione
Editor-in-Chief of Hematology Reports